 | • レポートコード：QYR2104Z0694 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、バクテリオファージ療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、非経口）、用途別市場規模（臓器移植、細菌感染症、アルコール性肝炎、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バクテリオファージ療法の市場動向 ・企業の競争状況、市場シェア ・バクテリオファージ療法の種類別市場規模（経口、局所、非経口） ・バクテリオファージ療法の用途別市場規模（臓器移植、細菌感染症、アルコール性肝炎、その他） ・バクテリオファージ療法の北米市場規模2016-2027（アメリカ、カナダ） ・バクテリオファージ療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バクテリオファージ療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バクテリオファージ療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・バクテリオファージ療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Armata Pharmaceuticals, Inc.、Eliava Biopreparations Ltd.、Pherecydes Pharma、Intralytix, Inc.、Phagelux Inc.、Nextbiotics、InnoPhage, Ltd、Locus Biosciences, Inc.、TechnoPhage、Eligo Bioscience SA、Phagomed Biopharma GmbH.、PhagePro, Inc.、Adaptive Phage Therapeutics, Inc.、EnBiotix, Inc.、Intodeworld, Inc.、BiomX Ltd.、Phi Therapeutics、Fixed-phage Ltd.、Micreos BV、ContraFect Corporation） ・結論 |
Phage therapy or viral phage therapy is the therapeutic use of bacteriophages to treat pathogenic bacterial infections. Bacteriophages, known as phages, are a form of viruses. Phages attach to bacterial cells, and inject a viral genome into the cell.
Market Analysis and Insights: Global Bacteriophage Therapy Market
The global Bacteriophage Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacteriophage Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacteriophage Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacteriophage Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacteriophage Therapy market.
Global Bacteriophage Therapy Scope and Market Size
Bacteriophage Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacteriophage Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Topical
Parenteral
Segment by Application
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriophage Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Topical
1.2.4 Parenteral
1.3 Market by Application
1.3.1 Global Bacteriophage Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage Therapy Market Perspective (2016-2027)
2.2 Bacteriophage Therapy Growth Trends by Regions
2.2.1 Bacteriophage Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bacteriophage Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Bacteriophage Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Bacteriophage Therapy Industry Dynamic
2.3.1 Bacteriophage Therapy Market Trends
2.3.2 Bacteriophage Therapy Market Drivers
2.3.3 Bacteriophage Therapy Market Challenges
2.3.4 Bacteriophage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacteriophage Therapy Players by Revenue
3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2016-2021)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bacteriophage Therapy Revenue
3.4 Global Bacteriophage Therapy Market Concentration Ratio
3.4.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2020
3.5 Bacteriophage Therapy Key Players Head office and Area Served
3.6 Key Players Bacteriophage Therapy Product Solution and Service
3.7 Date of Enter into Bacteriophage Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacteriophage Therapy Breakdown Data by Type
4.1 Global Bacteriophage Therapy Historic Market Size by Type (2016-2021)
4.2 Global Bacteriophage Therapy Forecasted Market Size by Type (2022-2027)
5 Bacteriophage Therapy Breakdown Data by Application
5.1 Global Bacteriophage Therapy Historic Market Size by Application (2016-2021)
5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bacteriophage Therapy Market Size (2016-2027)
6.2 North America Bacteriophage Therapy Market Size by Type
6.2.1 North America Bacteriophage Therapy Market Size by Type (2016-2021)
6.2.2 North America Bacteriophage Therapy Market Size by Type (2022-2027)
6.2.3 North America Bacteriophage Therapy Market Size by Type (2016-2027)
6.3 North America Bacteriophage Therapy Market Size by Application
6.3.1 North America Bacteriophage Therapy Market Size by Application (2016-2021)
6.3.2 North America Bacteriophage Therapy Market Size by Application (2022-2027)
6.3.3 North America Bacteriophage Therapy Market Size by Application (2016-2027)
6.4 North America Bacteriophage Therapy Market Size by Country
6.4.1 North America Bacteriophage Therapy Market Size by Country (2016-2021)
6.4.2 North America Bacteriophage Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bacteriophage Therapy Market Size (2016-2027)
7.2 Europe Bacteriophage Therapy Market Size by Type
7.2.1 Europe Bacteriophage Therapy Market Size by Type (2016-2021)
7.2.2 Europe Bacteriophage Therapy Market Size by Type (2022-2027)
7.2.3 Europe Bacteriophage Therapy Market Size by Type (2016-2027)
7.3 Europe Bacteriophage Therapy Market Size by Application
7.3.1 Europe Bacteriophage Therapy Market Size by Application (2016-2021)
7.3.2 Europe Bacteriophage Therapy Market Size by Application (2022-2027)
7.3.3 Europe Bacteriophage Therapy Market Size by Application (2016-2027)
7.4 Europe Bacteriophage Therapy Market Size by Country
7.4.1 Europe Bacteriophage Therapy Market Size by Country (2016-2021)
7.4.2 Europe Bacteriophage Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Therapy Market Size (2016-2027)
8.2 Asia-Pacific Bacteriophage Therapy Market Size by Type
8.2.1 Asia-Pacific Bacteriophage Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bacteriophage Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bacteriophage Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Bacteriophage Therapy Market Size by Application
8.3.1 Asia-Pacific Bacteriophage Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bacteriophage Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bacteriophage Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Bacteriophage Therapy Market Size by Region
8.4.1 Asia-Pacific Bacteriophage Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bacteriophage Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bacteriophage Therapy Market Size (2016-2027)
9.2 Latin America Bacteriophage Therapy Market Size by Type
9.2.1 Latin America Bacteriophage Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Bacteriophage Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Bacteriophage Therapy Market Size by Type (2016-2027)
9.3 Latin America Bacteriophage Therapy Market Size by Application
9.3.1 Latin America Bacteriophage Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Bacteriophage Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Bacteriophage Therapy Market Size by Application (2016-2027)
9.4 Latin America Bacteriophage Therapy Market Size by Country
9.4.1 Latin America Bacteriophage Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Bacteriophage Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Therapy Market Size (2016-2027)
10.2 Middle East & Africa Bacteriophage Therapy Market Size by Type
10.2.1 Middle East & Africa Bacteriophage Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bacteriophage Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bacteriophage Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Bacteriophage Therapy Market Size by Application
10.3.1 Middle East & Africa Bacteriophage Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bacteriophage Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bacteriophage Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Bacteriophage Therapy Market Size by Country
10.4.1 Middle East & Africa Bacteriophage Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bacteriophage Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Details
11.1.2 Armata Pharmaceuticals, Inc. Business Overview
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction
11.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.1.5 Armata Pharmaceuticals, Inc. Recent Development
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Details
11.2.2 Eliava Biopreparations Ltd. Business Overview
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction
11.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2016-2021)
11.2.5 Eliava Biopreparations Ltd. Recent Development
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Details
11.3.2 Pherecydes Pharma Business Overview
11.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction
11.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2016-2021)
11.3.5 Pherecydes Pharma Recent Development
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Details
11.4.2 Intralytix, Inc. Business Overview
11.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction
11.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.4.5 Intralytix, Inc. Recent Development
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Details
11.5.2 Phagelux Inc. Business Overview
11.5.3 Phagelux Inc. Bacteriophage Therapy Introduction
11.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.5.5 Phagelux Inc. Recent Development
11.6 Nextbiotics
11.6.1 Nextbiotics Company Details
11.6.2 Nextbiotics Business Overview
11.6.3 Nextbiotics Bacteriophage Therapy Introduction
11.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2016-2021)
11.6.5 Nextbiotics Recent Development
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Details
11.7.2 InnoPhage, Ltd Business Overview
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction
11.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2016-2021)
11.7.5 InnoPhage, Ltd Recent Development
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Details
11.8.2 Locus Biosciences, Inc. Business Overview
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction
11.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.8.5 Locus Biosciences, Inc. Recent Development
11.9 TechnoPhage
11.9.1 TechnoPhage Company Details
11.9.2 TechnoPhage Business Overview
11.9.3 TechnoPhage Bacteriophage Therapy Introduction
11.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2016-2021)
11.9.5 TechnoPhage Recent Development
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Details
11.10.2 Eligo Bioscience SA Business Overview
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction
11.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2016-2021)
11.10.5 Eligo Bioscience SA Recent Development
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Details
11.11.2 Phagomed Biopharma GmbH. Business Overview
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction
11.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2016-2021)
11.11.5 Phagomed Biopharma GmbH. Recent Development
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Details
11.12.2 PhagePro, Inc. Business Overview
11.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction
11.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.12.5 PhagePro, Inc. Recent Development
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Details
11.13.2 Adaptive Phage Therapeutics, Inc. Business Overview
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction
11.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.13.5 Adaptive Phage Therapeutics, Inc. Recent Development
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Details
11.14.2 EnBiotix, Inc. Business Overview
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction
11.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.14.5 EnBiotix, Inc. Recent Development
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Details
11.15.2 Intodeworld, Inc. Business Overview
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction
11.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2016-2021)
11.15.5 Intodeworld, Inc. Recent Development
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Details
11.16.2 BiomX Ltd. Business Overview
11.16.3 BiomX Ltd. Bacteriophage Therapy Introduction
11.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2016-2021)
11.16.5 BiomX Ltd. Recent Development
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Details
11.17.2 Phi Therapeutics Business Overview
11.17.3 Phi Therapeutics Bacteriophage Therapy Introduction
11.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2016-2021)
11.17.5 Phi Therapeutics Recent Development
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Details
11.18.2 Fixed-phage Ltd. Business Overview
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction
11.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2016-2021)
11.18.5 Fixed-phage Ltd. Recent Development
11.18 Micreos BV
.1 Micreos BV Company Details
.2 Micreos BV Business Overview
.3 Micreos BV Bacteriophage Therapy Introduction
.4 Micreos BV Revenue in Bacteriophage Therapy Business (2016-2021)
.5 Micreos BV Recent Development
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Details
11.20.2 ContraFect Corporation Business Overview
11.20.3 ContraFect Corporation Bacteriophage Therapy Introduction
11.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2016-2021)
11.20.5 ContraFect Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bacteriophage Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Key Players of Parenteral
Table 5. Global Bacteriophage Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bacteriophage Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bacteriophage Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bacteriophage Therapy Market Share by Regions (2016-2021)
Table 9. Global Bacteriophage Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bacteriophage Therapy Market Share by Regions (2022-2027)
Table 11. Bacteriophage Therapy Market Trends
Table 12. Bacteriophage Therapy Market Drivers
Table 13. Bacteriophage Therapy Market Challenges
Table 14. Bacteriophage Therapy Market Restraints
Table 15. Global Bacteriophage Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bacteriophage Therapy Market Share by Players (2016-2021)
Table 17. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriophage Therapy as of 2020)
Table 18. Ranking of Global Top Bacteriophage Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bacteriophage Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bacteriophage Therapy Product Solution and Service
Table 22. Date of Enter into Bacteriophage Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bacteriophage Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bacteriophage Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Bacteriophage Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bacteriophage Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bacteriophage Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bacteriophage Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Bacteriophage Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bacteriophage Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bacteriophage Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bacteriophage Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bacteriophage Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bacteriophage Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bacteriophage Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bacteriophage Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bacteriophage Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bacteriophage Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bacteriophage Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bacteriophage Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bacteriophage Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bacteriophage Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bacteriophage Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bacteriophage Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bacteriophage Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bacteriophage Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bacteriophage Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bacteriophage Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bacteriophage Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bacteriophage Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bacteriophage Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bacteriophage Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bacteriophage Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bacteriophage Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bacteriophage Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bacteriophage Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bacteriophage Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bacteriophage Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bacteriophage Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bacteriophage Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Armata Pharmaceuticals, Inc. Company Details
Table 63. Armata Pharmaceuticals, Inc. Business Overview
Table 64. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product
Table 65. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 66. Armata Pharmaceuticals, Inc. Recent Development
Table 67. Eliava Biopreparations Ltd. Company Details
Table 68. Eliava Biopreparations Ltd. Business Overview
Table 69. Eliava Biopreparations Ltd. Bacteriophage Therapy Product
Table 70. Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 71. Eliava Biopreparations Ltd. Recent Development
Table 72. Pherecydes Pharma Company Details
Table 73. Pherecydes Pharma Business Overview
Table 74. Pherecydes Pharma Bacteriophage Therapy Product
Table 75. Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 76. Pherecydes Pharma Recent Development
Table 77. Intralytix, Inc. Company Details
Table 78. Intralytix, Inc. Business Overview
Table 79. Intralytix, Inc. Bacteriophage Therapy Product
Table 80. Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 81. Intralytix, Inc. Recent Development
Table 82. Phagelux Inc. Company Details
Table 83. Phagelux Inc. Business Overview
Table 84. Phagelux Inc. Bacteriophage Therapy Product
Table 85. Phagelux Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 86. Phagelux Inc. Recent Development
Table 87. Nextbiotics Company Details
Table 88. Nextbiotics Business Overview
Table 89. Nextbiotics Bacteriophage Therapy Product
Table 90. Nextbiotics Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 91. Nextbiotics Recent Development
Table 92. InnoPhage, Ltd Company Details
Table 93. InnoPhage, Ltd Business Overview
Table 94. InnoPhage, Ltd Bacteriophage Therapy Product
Table 95. InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 96. InnoPhage, Ltd Recent Development
Table 97. Locus Biosciences, Inc. Company Details
Table 98. Locus Biosciences, Inc. Business Overview
Table 99. Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 100. Locus Biosciences, Inc. Recent Development
Table 101. TechnoPhage Company Details
Table 102. TechnoPhage Business Overview
Table 103. TechnoPhage Bacteriophage Therapy Product
Table 104. TechnoPhage Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 105. TechnoPhage Recent Development
Table 106. Eligo Bioscience SA Company Details
Table 107. Eligo Bioscience SA Business Overview
Table 108. Eligo Bioscience SA Bacteriophage Therapy Product
Table 109. Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 110. Eligo Bioscience SA Recent Development
Table 111. Phagomed Biopharma GmbH. Company Details
Table 112. Phagomed Biopharma GmbH. Business Overview
Table 113. Phagomed Biopharma GmbH. Bacteriophage Therapy Product
Table 114. Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 115. Phagomed Biopharma GmbH. Recent Development
Table 116. PhagePro, Inc. Company Details
Table 117. PhagePro, Inc. Business Overview
Table 118. PhagePro, Inc. Bacteriophage Therapy Product
Table 119. PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 120. PhagePro, Inc. Recent Development
Table 121. Adaptive Phage Therapeutics, Inc. Company Details
Table 122. Adaptive Phage Therapeutics, Inc. Business Overview
Table 123. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product
Table 124. Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 125. Adaptive Phage Therapeutics, Inc. Recent Development
Table 126. EnBiotix, Inc. Company Details
Table 127. EnBiotix, Inc. Business Overview
Table 128. EnBiotix, Inc. Bacteriophage Therapy Product
Table 129. EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 130. EnBiotix, Inc. Recent Development
Table 131. Intodeworld, Inc. Company Details
Table 132. Intodeworld, Inc. Business Overview
Table 133. Intodeworld, Inc. Bacteriophage Therapy Product
Table 134. Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 135. Intodeworld, Inc. Recent Development
Table 136. BiomX Ltd. Company Details
Table 137. BiomX Ltd. Business Overview
Table 138. BiomX Ltd. Bacteriophage Therapy Product
Table 139. BiomX Ltd. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 140. BiomX Ltd. Recent Development
Table 141. Phi Therapeutics Company Details
Table 142. Phi Therapeutics Business Overview
Table 143. Phi Therapeutics Bacteriophage Therapy Product
Table 144. Phi Therapeutics Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 145. Phi Therapeutics Recent Development
Table 146. Fixed-phage Ltd. Company Details
Table 147. Fixed-phage Ltd. Business Overview
Table 148. Fixed-phage Ltd. Bacteriophage Therapy Product
Table 149. Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 150. Fixed-phage Ltd. Recent Development
Table 151. Micreos BV Company Details
Table 152. Micreos BV Business Overview
Table 153. Micreos BV Bacteriophage Therapy Product
Table 154. Micreos BV Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 155. Micreos BV Recent Development
Table 156. ContraFect Corporation Company Details
Table 157. ContraFect Corporation Business Overview
Table 158. ContraFect Corporation Bacteriophage Therapy Product
Table 159. ContraFect Corporation Revenue in Bacteriophage Therapy Business (2016-2021) & (US$ Million)
Table 160. ContraFect Corporation Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacteriophage Therapy Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Topical Features
Figure 4. Parenteral Features
Figure 5. Global Bacteriophage Therapy Market Share by Application: 2020 VS 2027
Figure 6. Organ Transplantation Case Studies
Figure 7. Bacterial Infections Case Studies
Figure 8. Alcoholic Hepatitis Case Studies
Figure 9. Other Case Studies
Figure 10. Bacteriophage Therapy Report Years Considered
Figure 11. Global Bacteriophage Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bacteriophage Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bacteriophage Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Bacteriophage Therapy Market Share by Regions (2022-2027)
Figure 15. Global Bacteriophage Therapy Market Share by Players in 2020
Figure 16. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriophage Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2020
Figure 18. Global Bacteriophage Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Bacteriophage Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bacteriophage Therapy Market Share by Type (2016-2027)
Figure 22. North America Bacteriophage Therapy Market Share by Application (2016-2027)
Figure 23. North America Bacteriophage Therapy Market Share by Country (2016-2027)
Figure 24. United States Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bacteriophage Therapy Market Share by Type (2016-2027)
Figure 28. Europe Bacteriophage Therapy Market Share by Application (2016-2027)
Figure 29. Europe Bacteriophage Therapy Market Share by Country (2016-2027)
Figure 30. Germany Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bacteriophage Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bacteriophage Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bacteriophage Therapy Market Share by Region (2016-2027)
Figure 40. China Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bacteriophage Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Bacteriophage Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Bacteriophage Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bacteriophage Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bacteriophage Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bacteriophage Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bacteriophage Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 60. Eliava Biopreparations Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 61. Pherecydes Pharma Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 62. Intralytix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 63. Phagelux Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 64. Nextbiotics Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 65. InnoPhage, Ltd Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 66. Locus Biosciences, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 67. TechnoPhage Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 68. Eligo Bioscience SA Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 69. Phagomed Biopharma GmbH. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 70. PhagePro, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 71. Adaptive Phage Therapeutics, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 72. EnBiotix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 73. Intodeworld, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 74. BiomX Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 75. Phi Therapeutics Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 76. Fixed-phage Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 77. Micreos BV Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 78. ContraFect Corporation Revenue Growth Rate in Bacteriophage Therapy Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界のリンパ腫治療市場規模・現状・予測（2021年-2027年） Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control Market Analysis and Insights: Global L…- 世界の免疫細胞療法市場規模・現状・予測（2021年-2027年） Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy. Market Ana…
- 世界のホルモン補充療法（HRT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hormone Replacement Therapy (HRT) Market The global Hormone Replacement Therapy (HRT) market size is projected to reach US$ 4850.6 million by 2026, from US$ 3682.3 million in 2019, at a CAGR of 4.0% during 2021-2026. With industry-standard accuracy in analysis an…
- 世界の臓器移植市場規模・現状・予測（2021年-2027年） Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient, to replace a damaged or missing organ. The donor and recipient may be at the same location, or organs may be transported from a donor site to another location. Organs and/or…
- 世界の全身感染療法市場規模・現状・予測（2021年-2027年） Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the person’s bloodstream and gradually spreads to the whole body. The systemic infections can range from common ones such as flu, …